Haemorrhage, deep venous thrombosis, oedema leg

Stomatitis, diarrhoea, dyspepsia, dysphagia, mouth dry

Pharyngitis Rhinitis Pneumonia Upper respiratory tract infection Folliculitis

If a hereditary predisposition is suspected, the woman should be referred to a specialist for advice before deciding about any hormonal contraceptive use.

References

Venous disorder

Venous thromboembolism

Thrombosis embolism

Vascular disorders

Thrombosis (blood clotting).

Venous thromboembolism

5 Venous Thromboembolic Events

Thrombosis Very Common

Pulmonary artery thrombosis, Pulmonary thrombosis

Headache Shunt thrombosis Thrombocytosis

ed Blood clots (thrombosis)

Uncommon thrombophlebitis, hypertension, thrombosis

In case of suspected or confirmed thrombosis, hormonal contraceptive use should be discontinued.

Venous disorder (G3 4

thrombosis, cardiac tamponade, myocardial rupture

In the indication increasing the yield of autologous blood myocardial infarction or stroke in the month preceding treatment, unstable angina pectoris, increased risk of deep venous thrombosis such as history of venous thromboembolic disease.

3.4 ) Pyrexia (G3 4

Hypertension Hypotension Thrombosis Vasodilatation

Not known shock haemorrhagic, hypotension, thrombosis.

Rash Reproductive system and breast disorders Very rare

Thrombosis, hypotension, haemorrhage, vascular disorder, vascular anomaly

Vascular disorders including venoocclusive disease and fluid volume disturbances

Venous thrombotic events have been reported

An 15 increase in EE exposure can increase the incidence of adverse events associated with oral contraceptives (e. g., venous thrombo embolic events in women at risk).

An increase in EE exposure can increase the incidence of adverse events associated with oral contraceptives (e. g., venous thrombo embolic events in women at risk).

32 can increase the incidence of adverse events associated with oral contraceptives (e. g., venous thrombo embolic events in women at risk).

hepatitic artery thrombosis, venoocclusive liver disease hepatic failure, bile duct stenosis

Femoral artery thrombosis Capillary leak syndrome

Weakness or very marked numbness suddenly affecting one side or one part of the body

and function abnormalities, cholestasis and

hepatocellular damage and hepatitis, cholangitis rare hepatitic artery thrombosis, venoocclusive liver disease very rare

Combined hormonal contraceptives and blood clots (thrombosis) Using combined hormonal contraceptives, including EVRA, increases the chances of getting a thrombosis (blood clots).

Common (seen in more than 1 in 100 people) M

Therefore, thrombolytic therapy requires careful attention to all possible bleeding sites (including catheter insertion sites, arterial and venous puncture sites, cut down sites and needle puncture sites).

Micturition urgency Renal pain Urinary frequency

Taste disturbance, Paraesthesia and dysaesthesia, Peripheral neuropathy, Dysgeusia, Headache

Lower limb oedema, Hypertension, Embolism and thrombosis

The blood is then drained in the gastrointestinal tract and spleen, where it is taken up by the hepatic veins, and blood is taken back into the heart.

In the studied patient population of RE MODEL and RE NOVATE (5539 patients treated), 51 suffered from concomitant hypertension, 9 from concomitant diabetes, 9 from concomitant coronary artery disease and 20 had a history of venous insufficiency.

Antithrombotics are medicines which prevent the formation of blood clots (thrombosis).